E-LIB Suche - Ergebnisse für: Felix Huth

1

Use of Pharmacokinetic and Pharmacodynamic Data to Develop ..:

Ji, Yan ; Schiller, Hilmar ; Yang, Shu...
Clinical Pharmacokinetics. 63 (2024) 2 - p. 155-170 , 2024

Link: https://doi.org/10.1007/..

2

Identification of reversible OATP1B1 and time-dependent CYP..:

Kastrinou-Lampou, Vlasia ; Rodríguez-Pérez, Raquel ; Poller, Birk...
Archives of Toxicology. , 2024

Link: https://doi.org/10.1007/..

3

Interlaboratory Variability in the Madin–Darby Canine Kidne..:

Harwood, Matthew D. ; Zettl, Katharina ; Weinheimer, Manuel...
Molecular Pharmaceutics. 20 (2023) 7 - p. 3505-3518 , 2023

Link: https://doi.org/10.1021/..

4

Utilization of OATP1B Biomarker Coproporphyrin‐I to Guide D..:

Kikuchi, Ryota ; Chothe, Paresh P. ; Chu, Xiaoyan...
Clinical Pharmacology & Therapeutics. 114 (2023) 6 - p. 1170-1183 , 2023

Link: https://doi.org/10.1002/..

5

Novel insights into bile acid detoxification via CYP, UGT a..:

Kastrinou Lampou, Vlasia ; Poller, Birk ; Huth, Felix...
Toxicology in Vitro. 87 (2023) - p. 105533 , 2023

Link: https://doi.org/10.1016/..

6

Novel Bruton's tyrosine kinase inhibitor remibrutinib: Asse..:

Schiller, Hilmar ; Huth, Felix ; Schuhler, Carole...
European Journal of Pharmaceutical Sciences. 172 (2022) - p. 106155 , 2022

Link: https://doi.org/10.1016/..

7

Pharmacokinetics of asciminib in the presence of CYP3A or P..:

Hoch, Matthias ; Huth, Felix ; Sato, Masahiko...
Clinical and Translational Science. 15 (2022) 7 - p. 1698-1712 , 2022

Link: https://doi.org/10.1111/..

8

A kinase inhibitor which specifically targets the ABL myris..:

Manley, Paul W. ; Huth, Felix ; Moussaoui, Saliha.
Bioorganic & Medicinal Chemistry Letters. 59 (2022) - p. 128577 , 2022

Link: https://doi.org/10.1016/..

9

Pharmacokinetics of Asciminib When Taken With Imatinib or W..:

Hoch, Matthias ; Zack, Julia ; Quinlan, Michelle...
Clinical Pharmacology in Drug Development. 11 (2021) 2 - p. 207-219 , 2021

Link: https://doi.org/10.1002/..

10

Novel Bruton's Tyrosine Kinase inhibitor remibrutinib: Drug..:

Huth, Felix ; Schiller, Hilmar ; Jin, Yi...
Clinical and Translational Science. 15 (2021) 1 - p. 118-129 , 2021

Link: https://doi.org/10.1111/..

11

Predicting Oral Absorption for Compounds Outside the Rule o..:

Huth, Felix ; Domange, Norbert ; Poller, Birk...
Journal of Pharmaceutical Sciences. , 2021

Link: https://doi.org/10.1016/..

12

Ribociclib Drug‐Drug Interactions: Clinical Evaluations and..:

Samant, Tanay S. ; Huth, Felix ; Umehara, Kenichi...
Clinical Pharmacology & Therapeutics. 108 (2020) 3 - p. 575-585 , 2020

Link: https://doi.org/10.1002/..

13

Examining P-gp efflux kinetics guided by the BDDCS – Ration..:

Riede, Julia ; Umehara, Ken-Ichi ; Schweigler, Patrick...
European Journal of Pharmaceutical Sciences. 132 (2019) - p. 132-141 , 2019

Link: https://doi.org/10.1016/..

14

Prediction of the Impact of Cytochrome P450 2C9 Genotypes o..:

Huth, Felix ; Gardin, Anne ; Umehara, Kenichi.
Clinical Pharmacology & Therapeutics. 106 (2019) 5 - p. 1113-1124 , 2019

Link: https://doi.org/10.1002/..

15

Physiologically‐Based Pharmacokinetic Models for Evaluating..:

Taskar, Kunal S. ; Pilla Reddy, Venkatesh ; Burt, Howard...
Clinical Pharmacology & Therapeutics. 107 (2019) 5 - p. 1082-1115 , 2019

Link: https://doi.org/10.1002/..